Scott Weingarten, M.D., MPH, is the Chief Executive Officer of Stanson Health, a Premier company, and Chief Clinical and Innovation Officer of Premier, Inc. Dr. Weingarten is a professor of medicine and on the medical staff at Cedars-Sinai. He is also a health sciences clinical professor of medicine at the David Geffen School of Medicine at UCLA.
Prior to joining Premier, he was the Senior Vice President and Chief Clinical Transformation Officer at Cedars-Sinai. Dr. Weingarten has also worked as a primary care physician at Kaiser Permanente Woodland Hills. Board certified in internal medicine and a fellow of the American College of Physicians, Dr. Weingarten has published approximately 100 articles, book chapters, and editorials on healthcare improvement. Dr. Weingarten is a board member for the Downtown Women’s Center (DWC), which houses and feeds homeless women. He is a trustee of Charles Drew University School of Medicine and Science in Los Angeles. He is also a New England Journal of Medicine Catalyst “Thought Leader.”
Dr. Weingarten was a member of the National Academy of Medicine’s Committee on Clinical Decision Support. He is currently a Board of Director for the Scottsdale Institute. At Cedars-Sinai, he received the President’s Award, the Golden Apple Teaching Award, and the Alumnus of the Year. Dr. Weingarten was the co-founder, chief executive officer and chairman of the board of Stanson Health which he sold to Premier. Additionally, he was the co-founder, president and chief executive officer of Zynx Health, a company that he sold to Cerner Corporation and then to the Hearst Corporation. He is a co-inventor of three software patents granted by the United States Patent and Trademark Office.
After graduating from UCLA’s medical school, Dr. Weingarten completed his internship, residency and fellowship in internal medicine at Cedars-Sinai. He completed his M.P.H. at UCLA. He later participated in a National Center for Health Services Research Fellowship at the RAND/UCLA Center for Health Policy Study.